CD8A and neoplasm: The antitumor mechanisms of anti-CTLA-4 antibodies primarily include the following two effects: (1) modulation of tumor-specific immune effector cells, for instance, affecting CD8+ T cells to promote clonal proliferation and (2) removal of Tregs to relieve the inhibition of the tumor-directed immune response [81].